Sinusitis: Bench to Bedside Current Findings, Future Directions

Journal of Allergy and Clinical Immunology

Volumn 99, Issue 6 SUPPL. 2, 1997, Pages

  Kaliner, Michael A ^a,i   David Osguthorpe, J ^b   Fireman, Philip ^c   Anon, Jack ^d   Georgitis, John ^e   Davis, Mary L ^f   Naclerio, Robert ^g   Kennedy, David ^h  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b Medical University of South Carolina   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f American Academy of Allergy   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ American Academy of Allergy Asthma & Immunology   (United States)

Author keywords

Allergy; Otolaryngology; Public health sinusitis; Sinus surgery; Sinusitis

Indexed keywords

CHRONIC SINUSITIS; CONFERENCE PAPER; CYSTIC FIBROSIS; DISEASE ASSOCIATION; HEALTH CARE COST; HUMAN; IMMUNOPATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT PLANNING; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ASTHMA; CHRONIC DISEASE; COST OF ILLNESS; EOSINOPHILS; HUMANS; NASAL POLYPS; PARANASAL SINUSES; RHINITIS; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0031011871     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(97)70041-1     Document Type: Article

References (89)

1. Gwaltney JM Jr, Phillis CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330:25-30.
2. Kennedy DW. International conference on sinus disease: terminology, staging, therapy. Ann Otol Rhinol Laryngol 1995;104(10).
3. Benson V, Marano MA. Current estimates from the 1993 National Health Interview Survey. National Center for Health Statistics. Vital Health Stat 1994;10(190).
4. Collins JG. Prevalence of selected chronic conditions: United States, 1986-88. National Center for Health Statistics. Vital Health Stat 1993;10:l-87.
5. Hahn B, Lefkowitz D. Annual expenses and sources of payment for health care services. Rockville (MD): Public Health Service, National Expenditure Survey Research Findings 14, Agency for Health Care Policy and Research, Publication No. 93-0007, 1994.
6. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-9.
7. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new quality of life instrument. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. New York: Raven Press; 1995. p. 49-56.
8. Patrick D, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27(3 Suppl):S217-32.
9. Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 1995;4:27-32.
10. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I, Conceptual framework and item selection. Med Care 1992;30:473-83.
11. Gljklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngo) Head NeckSurg 1995;113:104-9.
12. Hoffman SR, Mahoney MC, Chmiel JF, Stinziano GD, Hoffman KN. Symptom relief after endoscopie sinus surgery: an outcomes-based study. Ear Nose Throat J 1993;72:413-4, 419-20.
13. Gliklich RE, Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope 1995;105(4 Pt 1):387-90.
14. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head NeckSurgl995;113:104-9.
15. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549-57.
16. Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993;265(5 Pt l):L472-8.
17. Elias JA, Zheng T, Einarsson O, et al. Epithelial interleukin11: regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 1994;269:22261-8.
18. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 1995;154:799-803.
19. Wellicome SM, Thornhill MH, Pitzalis C, et al. A monoclonal antibody that detects a novel antigen on endothelial cells that are induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J Immunol 144(7):2558-65.
20. Groves RW, Ross E, Barker JN, Ross JS, Camp RD, MacDonald DM. Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest Dermatol 1992;98:384-7.
21. Groves RW, Allen MH, Ross EL, Barker JM, MacDonald DM. Tumor necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol 1995;132:345-52.
22. Hamilos DL, Leung DYM, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
23. Denburg JA, Gauldie J, Dolovich J, Ohtoshi T, Cox G, Jordana M. Structural cell-derived cytokines in allergic inflammation. Int Arch Allergy Appl Immunol 1991;94:127-32.
24. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage colony-stimulating factor and interleukin-6 and interleukin-8 in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:1001-9.
25. Dolovich I, Ohtoshi T, Jordana M, Gauldie J, Denburg J. Nasal polyps: local inductive microenvironment in the pathogenesis of the inflammation. In: Mygind N, Pipkorn U, Pipkorn D, editors. Copenhagen: Munksgaard; 1990. p. 233- 41.
26. Finotto S, Ohno I, Marshall JS, et al. TNF-alpha production by eosinophils in upper airway inflammation (nasal polyposis). J Immunol 1994; 153:2278-89.
27. Slavin RG. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps. J Allergy Clin Immunol 1988;82(5 Pt 2):950-6.
28. Hamilos DL, Leung DYM, Wood R, et al. Chronic hyerplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3. J Allergy Clin Immunol 1993;91(1 Pt l):39-48.
29. Hamilos DL, Leung DYM, Wood R, et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
30. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992;148:2390-4.
31. Igarashi Y, Goldrich MS, Kaliner MA, Irani AMM, Schwartz LB, White MV. Quantification of inflammatory cells in the nasal mucosa of allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995;95:716-25.
32. Moss RB, Scott TA, Goldrich M, et al. Nasal mucosal cells in HIV-1 seropositive patients with sinusitis. J Clin Lab Anal. In press.
33. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide in human paranasal sinuses. Nat Med 1995;l:370-3.
34. Jain B, Rubenstein I, Robbins RA, Leishe KL, Sisson JH. Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 1993;191:83-8.
35. Lundberg JO, Weitzberg E, Nordvall SL, Kuylensticrna R, Lundberg JM, Alving K. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994;7:1501-4.
36. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodialtor reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47.
37. Lundberg JO, Lundberg M, Settergren G, Alving K, Weitzberg E. Nitric oxide, produced in the upper airways, may act in an 'aerocrine' fashion to enhance pulmonary oxygen uptake in humans. Acta Physiol Scand 1995;155:467-8.
38. Baraniuk JN. Neural control of human nasal secretion. Pulm Pharmacol 1991;4:20-31.
39. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract: Part I. Am Rev Respir Dis 1991;144:118798.
40. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract: Part II. Am Rev-Respir Dis 1991;144:1391-9.
41. Dray A, Urban L, Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sei 1994;15:190-7.
42. Stjarne P, Lacroix JS, Anggard A, Lundberg JM. Compartment analysis of vascular effects of neuropeptides and capsaicin in the pig nasal mucosa. Acta Physiol Scand 1991;141:335-42.
43. Braunstein G, Fajac I, Lacronique J, Frossard N. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 1991;144(3 Pt l):630-6.
44. Tokuyama K, Kuo HP, Rohode JA, Barnes PJ, Rogers DF. Neural control of goblet cell secretion in guinea pig airways. Am J Pbysiol 1990;259(2 Pt 1):L108-15.
45. Cervin A, Lindberg S, Mercke U. Sympathetic nerve Stimulation influences mucociliary activity in the rabbit maxillary sinus. Acta Physiol Scand 1991;143:405-11.
46. Okamoto Y, Shirotori K, Kudo K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993;151:4391-8.
47. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 1993;151:3274-82.
48. Ohno I, Lea R, Finotto S, et al. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils and nasal polyposis. Am J Respir Cell Mol Biol 1991;5:505-10.
49. Jeney EV, Raphael GD, Meredith SD, Baraniuk JN, Kaliner MA. Nasal secretions in recurrent sinusitis. J Allergy Clin Immunol 1990;86:10-8.
50. Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A. Deisel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 1994;94:1417-25.
51. Brezillon S, Dupuit F, Hinnrasky J, et al. Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients. Lab Invest 1995;72:191200.
52. Waltner WE, Church NL, Gatzy JT, Boucher RC, Knowles MR. Deposition, pharmacokinetics and toxicity of amiloride aeorsol in normal and cystic fibrosis subjects. Am Rev Respir Dis 1987;135:288A.
53. Rachelefsky GS, Goldberg M, Katz RM, et al. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978 ;61:310-4.
54. Adinoff AD, Cummings NP. Sinusitis and its relationship to asthma. Pediatr Ann 1989; 18:785-90.
55. Businco L, Fiore L, Frediani T, Artuso A, Di Fazio A, Bellioni P. Clinical and therapeutic aspects on sinusitis in children with bronchial asthma. Int J Pediatr Otorhinolaryngol 1981 ;3:287-94.
56. Rachelefsky GS, Katz RM, Siegel SC. Chronic sinus disease with associated reactive airway disease in children. Pediatrics 1984:73:526-9.
57. Zimmerman B, Stringer D, Feanny S, et al. Prevalence of abnormalities found by sinus x-rays in childhood asthma: lack of relation to severity of asthma. J Allergy Clin Immunol 1987;80(3 Pt l):268-73.
58. Shapiro GG. Role of allergy in sinusitis. Pediatr Infect Disease 1985;4(6 Suppl):S55-9.
59. Shapiro GG, Virant FS, Furukawa CT, Pierson WE, Bierman CW. Immunologie defects in children with refractory sinusitis. Pediatrics 1991;87:311-6.
60. Newman LI, Platts-Mills TA, Phillips CD, Hazen KC, Gross CW. Chronic sinusitis: Relationship of computed tomographic findings to allergy, asthma and eosinophilia. JAMA 1994:271:363-7.
61. McNally PA, White MV, Kaliner MA. Sinusitis in an allergist's office: analysis of 200 consecutive cases. Allergy Asthma Proc. In press.
62. Hamory BH, Sande MA, Sydnor A Jr, Seale DL, Gwaltney JM Jr. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979:139:197-202.
63. Dingle JH, Badger GF, Jordan WS Jr. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland: The Press of Western Reserve University; 1964. p. 347.
64. Berg O, Carenfelt C, Rystedt G, Anggard A. Occurrence of asymptomatic sinusitis in common cold and other acute ENTinfections. Rhinology 1986;24:223-5.
65. Evans FO Jr, Sydnor JB, Moore WE, et al. Sinusitis of the maxillary antrum. N EnglJMed 1975:293:735-9.
66. Orobello PW Jr, Park RI, Belcher LJ, et al. Microbiology of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg 1991;117:980-3.
67. Karma P, Jokipii L, Sipila P, Luotonen J, Jokipii AM. Bacteria in chronic maxillary sinusitis. Arch Otolaryngol 1979; 105:386-90.
68. Muntz HR, Lusk RP. Bacteriology of the ethmoid bullae in children with chronic sinusitis. Arch Otolaryngol Head Neck Surg 1991:117:179-81.
69. Gwaltney JM Jr. State-of-the-art: acute community- acquired sinusitis. Clin Infect Dis 1996;23:1209-23.
70. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 3-center national surveillance study. Antimicrob Agents Chemother 1996;40:1208-13.
71. Gwaltney JM Jr, Scheid WM, Sande MA, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992;90:457-62.
72. Wald ER, Chiponis D, Ledesma-Medina J. Comparative effectiveness of amoxicillin and amoxicillin-clavulanate potassium in acute paranasal sinus infections in children; a double-blind, placebo-controlled trial. Pediatrics 1986;77:795-800.
73. Wald ER. Chronic sinusitis in children. J Pediatr 1995;127:339-47.
74. Tinkleman DG, Silk HJ. Clinical and bactériologie features of chronic sinusitis in children. Am J Dis Child 1989; 143:938-41.
75. Otten FW, Grote JJ. Treatment of chronic maxillary sinusitis in children. Int J Pediatr Otorhinolaryngol 1988;15:269-78.
76. Muntz HR, Lusk RP. Bacteriology of the ethmoid bullae in children with chronic sinusitis. Arch Otolaryngol Head Neck Surg 1991:117:179-81.
77. Orobello PW Jr, Park RI, Belcher LJ, et al. Microbiology of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg 1991;! 17:980-3.
78. Sykes DA, Wilson R, Chan KL, Mackay IS, Cole PJ. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: a controlled study. Lancet 1986;2:359-60.
79. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:812-23.
80. Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990; 103(5 Pt 2):880-3.
81. Ziment I. Help for an overtaxed mucociliary system: managing abnormal mucus. J Resp Dis 1991;12:21-33.
82. Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of-sinonasal disease in patients injected with human immunodeficiency virus (HIV). Laryngoscope 1992;102:1225-8.
83. Lusk RP, Lazar RH, Muntz HR. The diagnosis and treatment of recurrent and chronic sinusitis in children. Pediatr Clin North Am 1989:36:1411-21.
84. Evans FO, Syndor JB, Moore WE. Sinusitis of the maxillary anturm. N Engl J Med 1975;293:735-9.
85. Zinreich SJ, Kennedy DW, Rosenbaum AE, et al. Paranasal sinuses: CT imaging requirements for endoscopie surgery. Radiology 1987; 163:764-75.
86. Kennedy DW, Zinreich SJ, Rosenbaum AE, Johns ME. Functional endoscopie sinus surgery: theory and diagnostic evaluation. Arch Otolaryngol Head Neck Surg 1985;lll:576-82.
87. Bolger WE. Gram negative sinusitis: an emerging clinical entity. Am J Rhinol 1994;8:279-84.
88. Hsu J, Lanza DC, Kennedy DW. Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol. In press.
89. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992;102(12).